WASHINGTON - An advisory panel for the U.S. Food and Drug Administration on Friday will meet to consider whether there is enough proof that a booster dose of Pfizer-BioNTech’s COVID-19 vaccine for Americans is safe and effective.
The FDA’s independent panel of advisers will also vote on whether the agency should approve the additional dose for those 16 and older.
The U.S. has already approved an extra dose of both the Pfizer or Moderna vaccines to people who are immunocompromised — or those with severely weakened immune systems.The meeting is being livestreamed online for the public to view, scheduled to last until around 3:45 p.m.